SCHEMBL6809012

SCHEMBL6809012

CC(c1ccc(C[C]=O)cc1)n1cncc1-c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
CYP11B1 P15538 8/20 0.42
CYP11B2 P19099 8/20 0.42
GABRA1 P14867 5/20 0.42
GABRB2 P47870 4/20 0.42
CYP1A2 P05177 2/20 0.42
CYP3A4 P08684 2/20 0.42
LMNA P02545 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
ABCB11 O95342 1/20 0.42
GABRA2 P47869 1/20 0.42
MAPK1 P28482 1/20 0.41
IDO1 P14902 1/20 0.40
CYP17A1 P05093 1/20 0.37
GPBAR1 Q8TDU6 3/20 0.36
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3493490 0.82 ALDH1A1 (0.58) ALDH1A1TDP1CYP11B1CYP11B2GABRA1
SCHEMBL6809013 0.73 CYP11B1 (0.52) CYP11B1CYP11B2IDO1
SCHEMBL1271150 0.66 TAAR1 (0.50) ALDH1A1LMNAIDO1
SCHEMBL24966825 0.65 ALDH1A1 (0.59) ALDH1A1TDP1CYP11B1CYP11B2GABRA1
SCHEMBL21238502 0.65 ALDH1A1 (0.62) ALDH1A1TDP1CYP11B1CYP11B2GABRA1
SCHEMBL28264228 0.65 SLC6A2 (0.40) LMNACYP2C19MAPK1
SCHEMBL8943574 0.64 IDO1 (0.47) IDO1SMN1; SMN2
SCHEMBL14139039 0.64 ALDH1A1 (0.61) ALDH1A1TDP1CYP11B1CYP11B2GABRA1
SCHEMBL14098467 0.64 ALDH1A1 (0.61) ALDH1A1TDP1CYP11B1CYP11B2GABRA1
SCHEMBL1081228 0.62 ALDH1A1 (1.00) ALDH1A1TDP1CYP11B1CYP11B2GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6770647-B2 Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE) BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-08-03 US disclosed